Yong‐Mi Kim - Concepedia

Author

Yong‐Mi Kim

Also Known As

Academic Society of Global Business Administration, Kim, Kim, Y.-M., Kim, Yong Mi, Kim, Yong-Mi, Kyung Mi Kim, Mi-Jeong Choi, Y M Kim, Y-M Kim, Y-M. Kim

337

Publications

8.2K

Citations

H-Index

221

Concepts

All Affiliations

University of Southern California Children's Hospital of Los Angeles University of Michigan University of Oklahoma Heinrich Heine University Düsseldorf

About

Yong‐Mi Kim is an author at University of Southern California specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	9	9	431
2	Business	7	7	573
3	Health Sciences	7	7	563
4	Education	4	4	261
5	Arts	2	2	52

Yong‐Mi Kim

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity Sajid Khan, Xuan Zhang, Dongwen Lv, Nature Medicine OncologyMedicinePotent Antitumor ActivityImmune Checkpoint InhibitorAnti-cancer Agent	2019	608
IT Outsourcing Strategies: Universalistic, Contingency, and Configurational Explanations of Success Jae-Nam Lee, Shaila M. Miranda, Yong‐Mi Kim Information Systems Research Individual Outsourcing DecisionsResidual Rights TheoryIct GovernanceIndustrial OrganizationOrganizational Behavior	2004	427
Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells Markus Y. Mapara, Yong‐Mi Kim, Shengping Wang, Blood	2002	237
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells M.-s. Jung, Jin Kyung Rho, Yong‐Mi Kim, Oncogene Tumor BiologyMedicineStem Cell MobilizationStem CellsStem Cell Research	2012	201
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition Cihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, Nature Hematological MalignancyCancer ResearchMixed-phenotype Acute LeukemiaImmunologyCancer Cell Biology	2011	200
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression Kristen Fousek, Junji Watanabe, Sujith K. Joseph, Leukemia	2020	181
Adoption of Library 2.0 Functionalities by Academic Libraries and Users: A Knowledge Management Perspective Yong‐Mi Kim, June Abbas The Journal of Academic Librarianship Information LiteracyLibrary DesignAcademic LibrariesEducationKnowledge Management	2010	175
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia Christian Hurtz, Katerina Hatzi, Leandro Cerchietti, The Journal of Experimental Medicine	2011	174
The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia Lars Klemm, Cihangir Duy, Ilaria Iacobucci, Cancer Cell Hematological MalignancyChronic Myeloid LeukemiaHealth SciencesHematologyImmunology	2009	159
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia Eun Ji Gang, Y-T Hsieh, Jennifer Pham, Oncogene Cbp/catenin InteractionsHematological MalignancyMedicineMalignant Blood DisorderMixed-phenotype Acute Leukemia	2013	156

Page 1